Healthcare & Medical Devices Global On demand · 24-48h

Global Veterinary Viral Detection Kit Market Strategic Research Report

Global Veterinary Viral Detection Kit Market Strategic Resea…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Veterinary Viral Detection Kit Market
$1.08B2025
12.8%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: 25 Tests/Box, 50 Tests/Box, 96 Tests/Box

By Application: Livestock Farming, Pets, Universities and Research Institutes

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: IDEXX Laboratories, Thermo Fisher Scientific, Innovative Diagnostics, Gold Standard Diagnostics, Neogen, BioChek, EWC Diagnostics, Eurofins Technologies, BioStone Animal Health, Bioguard, Zoetis, FlashTest, Beaverbio, Singuway, Lifereal, Tianlong Technology, Takara Bio, Nippon Gene

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 136 pages
Market size 2025
$1.08B
Billion USD
Forecast CAGR
12.8%
2025-2032
Forecast 2032
$2.5B
Projected
Regiões
5
Asia Pacific · Latin America · MEA · Europe · North America

Visão geral

Scope of the Report

The global Veterinary Viral Detection Kit market size is predicted to grow from US$ 1,079 million in 2025 to US$ 2,489 million in 2032; it is expected to grow at a CAGR of 12.8% from 2026 to 2032.

Veterinary virus detection kits are in vitro diagnostic products designed to detect viral pathogens, viral antigens, viral nucleic acids, or host-specific antibodies within animal samples. They primarily serve applications such as animal disease screening, clinical diagnosis, evaluation of immunization efficacy, epidemic surveillance, and import/export quarantine. The samples analyzed typically include serum, plasma, whole blood, throat swabs, nasal swabs, anal swabs, feces, tissue, and secretions. Detection methods employed include fluorescence PCR/RT-PCR, LAMP, ELISA, colloidal gold immunochromatography, fluorescence immunochromatography, and multiplex nucleic acid detection. These kits are widely utilized for the detection of viral diseases in swine, cattle, sheep, poultry, dogs, cats, aquatic animals, and wildlife—covering pathogens such as African Swine Fever, Avian Influenza, Foot-and-Mouth Disease, Classical Swine Fever, Porcine Reproductive and Respiratory Syndrome (PRRS), Canine Distemper, Canine Parvovirus, and Feline Coronavirus. Consequently, they constitute a vital tool in veterinary diagnostics, biosecurity management on livestock farms, and the prevention and control of animal diseases.

The upstream segment of the veterinary virus detection kit industry chain primarily comprises suppliers of antigens, antibodies, enzymes, primers and probes, nucleic acid extraction reagents, buffers, chromogenic substrates, colloidal gold/fluorescent microspheres, NC membranes, microtiter plates, plastic consumables, packaging materials, and automated detection instruments. Among these, core raw materials—such as antigens, antibodies, enzymes, primers, and probes—are characterized by high technological barriers, and certain high-end raw materials remain dependent on imports. The midstream segment consists of enterprises engaged in the R&D, regulatory registration, manufacturing, and sales of veterinary virus detection kits; their product portfolios include fluorescence PCR/RT-PCR kits, ELISA antibody detection kits, rapid antigen test cards, colloidal gold test strips, and multiplex nucleic acid detection products. The downstream segment primarily serves animal disease control centers, customs and quarantine agencies, veterinary laboratories, large-scale livestock farms, veterinary clinics, research institutes, and third-party testing organizations. The gross profit margin for veterinary virus detection kits typically stands at approximately 40%.

In 2025, the average price of veterinary virus detection kits is $8 per unit, with sales reaching 137.87 million units and a total production capacity of 197 million units.

The market for veterinary virus detection kits is expected to maintain relatively stable growth in the future. This outlook is driven primarily by large-scale animal farming, biosecurity and disease control measures, routine animal disease surveillance, upgrading trends in pet healthcare consumption, and increasing demand for import and export quarantine inspections. Compared to traditional clinical diagnostics, veterinary virus detection places a greater emphasis on speed, accuracy, cost-effectiveness, and field-operability. Consequently, fluorescence PCR and RT-PCR remain the dominant technologies for the definitive diagnosis and laboratory-based testing of major animal diseases; ELISA is well-suited for antibody monitoring and immune status evaluation; while colloidal gold and fluorescence immunochromatography are better suited for rapid screening in livestock farms, veterinary clinics, and grassroots-level institutions. In the future, the industry's competitive focus will shift from the mere sale of individual reagents to the provision of comprehensive solutions—encompassing "detection kits + diagnostic instruments + automated platforms + data management + disease control services." Furthermore, products are expected to evolve toward multiplex assays, rapid point-of-care testing, digital PCR, high-sensitivity immunoassays, and the substitution of imported core raw materials with domestically produced alternatives. Overall, while demand within this industry is inherently inelastic, it remains significantly influenced by regulatory policies, disease outbreak cycles, centralized procurement pricing, distribution channel coverage, and product registration barriers. Consequently, leading enterprises—as well as manufacturers possessing proprietary core raw materials, molecular diagnostic platforms, and established veterinary distribution channels—are best positioned to hold a competitive advantage.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Veterinary Viral Detection Kit market?

What factors are driving Veterinary Viral Detection Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Veterinary Viral Detection Kit market opportunities vary by end market size?

How does Veterinary Viral Detection Kit break out by Type, by Application?

This report presents a comprehensive overview of the global Veterinary Viral Detection Kit market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • 25 Tests/Box
  • 50 Tests/Box
  • 96 Tests/Box

Segment by Sample Type

  • Serum Plasma Sample Type
  • Whole Blood Sample Type
  • Swab Sample Type
  • Fecal Sample Type
  • Tissue Sample Type

Segment by Detection Throughput

  • Single-Analyte Detection Kit
  • Multi-Analyte Detection Kit

Segment by Application

  • Livestock Farming
  • Pets
  • Universities and Research Institutes

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Veterinary Viral Detection Kit market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Livestock Farming, Pets, Universities and Research Institutes evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Veterinary Viral Detection Kit Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 12.8%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.08B
2025
Forecast
$2.5B
2032
CAGR
12.8%
2025–2032
Regiões
5
global
Key companies
IDEXX LaboratoriesThermo Fisher ScientificInnovative DiagnosticsGold Standard DiagnosticsNeogenBioChekEWC DiagnosticsEurofins Technologies
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
25 Tests/Box50 Tests/Box96 Tests/Box
By Application
Livestock FarmingPetsUniversities and Research Institutes

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 25 Tests/Box
  • 3.1.3 50 Tests/Box
  • 3.1.4 96 Tests/Box
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Livestock Farming
  • 4.1.3 Pets
  • 4.1.4 Universities and Research Institutes
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 IDEXX Laboratories
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Thermo Fisher Scientific
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Innovative Diagnostics
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Gold Standard Diagnostics
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Neogen
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 BioChek
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 EWC Diagnostics
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Eurofins Technologies
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 BioStone Animal Health
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Bioguard
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Zoetis
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 FlashTest
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Beaverbio
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Singuway
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Lifereal
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Tianlong Technology
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Takara Bio
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Nippon Gene
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Veterinary Viral Detection Kit market?
The global Veterinary Viral Detection Kit market is estimated at US$ 1.08 billion in 2025 (base year) and is projected to reach US$ 2.49 billion by 2032.
How fast is the Veterinary Viral Detection Kit market expected to grow?
The market is expected to grow at a CAGR of 12.8% from 2026 to 2032, expanding from US$ 1.08 billion in 2025 to US$ 2.49 billion in 2032, roughly 2.3 times its base-year value.
What does the Veterinary Viral Detection Kit market cover?
Veterinary virus detection kits are in vitro diagnostic products designed to detect viral pathogens, viral antigens, viral nucleic acids, or host-specific antibodies within animal samples. They primarily serve applications such as animal disease screening, clinical diagnosis, evaluation of immunization efficacy, epidemic surveillance, and import/export quarantine. The samples analyzed typically include serum, plasma, whole blood, throat swabs, nasal swabs, anal swabs, feces, tissue, and secretions.
How is the Veterinary Viral Detection Kit market segmented by type?
By type, the market is segmented into 25 Tests/Box, 50 Tests/Box and 96 Tests/Box.
What are the key applications of Veterinary Viral Detection Kit?
Key applications covered include Livestock Farming, Pets and Universities and Research Institutes.
Which companies are profiled in the Veterinary Viral Detection Kit market report?
Key players profiled include IDEXX Laboratories, Thermo Fisher Scientific, Innovative Diagnostics, Gold Standard Diagnostics, Neogen, BioChek, EWC Diagnostics and Eurofins Technologies, among 18 companies covered in total.
What geographies does the Veterinary Viral Detection Kit market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Veterinary Viral Detection Kit?
This outlook is driven primarily by large-scale animal farming, biosecurity and disease control measures, routine animal disease surveillance, upgrading trends in pet healthcare consumption, and increasing demand for import and export quarantine inspections.
What are the main risks and barriers in the Veterinary Viral Detection Kit market?
Among these, core raw materials—such as antigens, antibodies, enzymes, primers, and probes—are characterized by high technological barriers, and certain high-end raw materials remain dependent on imports.
Who should buy the Veterinary Viral Detection Kit market report?
The report is intended for manufacturers and solution providers, distributors and end users in Livestock Farming, Pets and Universities and Research Institutes, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Veterinary Viral Detection Kit market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.